Skip to content

Pacific Biosciences of California PACB Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$18M-5.9%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$77.42M
Azenta logo
AzentaAZTA
$363.08M
CareDx logo
CareDxCDNA
$80.6M+0.9%
Illumina logo
IlluminaILMN
Bruker logo
BrukerBRKR

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's finite lived intangible assets - gross?
Pacific Biosciences of California (PACB) reported finite lived intangible assets - gross of $421.54M in Q1 2026.
How has Pacific Biosciences of California's finite lived intangible assets - gross changed year-over-year?
Pacific Biosciences of California's finite lived intangible assets - gross decreased by 0.0% year-over-year, from $421.54M to $421.54M.
What is the long-term trend for Pacific Biosciences of California's finite lived intangible assets - gross?
Over 4 years (2021 to 2025), Pacific Biosciences of California's finite lived intangible assets - gross has grown at a 146.8% compound annual growth rate (CAGR), from $11.36M to $421.54M.
What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.